Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

IF 6.1 1区医学 Q1 ONCOLOGY

Breast Cancer Research Pub Date : 2022-03-21 DOI:10.1186/s13058-022-01519-x

H. Won, J. Ahn, Y. Kim, Jin Sung Kim, J. Song, Hong-Kyu Kim, Jeeyeon Lee, H. Park, Yong-Seok Kim

引用次数: 12

查看原文本刊更多论文

her2低表达在早期乳腺癌中的临床意义:韩国乳腺癌协会的一项全国性研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast Cancer Research 医学-肿瘤学

自引率

0.00%

发文量

期刊介绍： Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.